Saadet ALAN, Ayse Nur AKATLİ

Histopathological gastric mucosal changes in patients using proton pump inhibitors

As a result of the widespread use of proton pump inhibitors (PPI), parietal cell hyperplasia/ hypertrophy (PCH/H) and a significant increase in fundic gland polyp (FGP) is observed in gastric mucosa in recent years. The aim of this study is to evaluate clinical and histopathological results of patients diagnosed with PCH/H and FGP. Clinical data and archieved slides of 60 patients who were diagnosed with PCH/H or FGP at our institution between 2012-2019 were reviewed. Of the patients included in the study , 40 were women and 20 were men. Thirty-three cases, diagnosed with PCH/H and 27 cases diagnosed with FGP were investigated. H. Pylori gastritis was seen in 6 cases. In one case with a FGP, micronodular-linear neuroendocrine cell hyperplasia was observed. The FGPs, developing in the later stages of PPI use, are identified by endoscopic and pathological findings. Enterocromafine cell-like hyperplastic changes can become apparent in patients using PPI. H. Pylori gastritis was found to be less common in patients diagnosed with FGP and PCH/H than in the general population.

PDF

___

1. Kato M, Miyamoto S, Proton pump ınhibitor-associated mucosal change. Intern Med. 2017;15;56:2697.

2. Brito HLF, Barros C, Freire MV, et al. Gastric Fundic Gland Polyps: Can Histology Be Useful To Predict Proton Pump İnhibitors Use? Arq Gastroenterol. 2018;55:380-4.

3. Camilo SM, Almeida ÉC, Miranzi BA, et al. Endoscopıc And Hıstopathologıc Gastrıc Changes In Chronıc Users Of Proton-Pump Inhıbıtors. Arq Gastroenterol. 2015;52:59-64.

4. Declich P, Belloni J, Tavani E, et al. Fundic gland polyps and proton pump inhibitors: an obvious link, or an open question? Hum Pathol. 2014;45:1122-3.

5. Cheesman AR, Greenwald DA, Shah SC. Current Management of Benign Epithelial Gastric Polyps. Curr Treat Options Gastroenterol. 2017;15:676-90.

6. Olmez S, Sayar S, Saritas B, et al. Evaluation of patients with gastric polyps. North Clin Istanb. 2018;10;5:41-6.

7. Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24:1341-8.

8. Sekine S, Shibata T, Yamauchi Y, et al. β-Catenin mutations in sporadic fundic gland polyps. Virchows Archiv. 2001;440:381-6.

9. Rubio CA. Plugs clog the glandular outlets in fundic gland polyps. Int J Clin Exp Pathol. 2010;3:69-74.

10. Torbenson M, Lee J-H, Cruz-Correa M, et al. Sporadic Fundic Gland Polyposis: A Clinical, Histological, and Molecular Analysis. Mod Pathol. 2002;15:718-23.

11. Abraham SC, Park SJ, Mugartegui L, et al. Sporadic Fundic Gland Polyps with Epithelial Dysplasia. Am J Pathol. 2002;161:1735-42.

12. Genta RM, Schuler CM, Robiou CI, et al. No Association Between Gastric Fundic Gland Polyps and Gastrointestinal Neoplasia in a Study of Over 100,000 Patients. Clin Gastroenterol Hepatol. 2009;7:849-54.

13. Cats A, Edschenk B, Bloemena E, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000;31:684-90.

14. Abraham SC. Fundic Gland Polyps: Common and Occasionally Problematic Lesions. Gastroenterol Hepatol (N Y). 2010;6:48-51.

15. Takahari K, Haruma K, Ohtani H, et al. Proton pump inhibitor induction of gastric cobblestone-like lesions in the stomach. Intern Med 2017;56:2699-703.

16. Jianu CS, Lange OJ, Viset T, et al. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor. Scand J Gastroenterol. 2012;47:64-7